Get the SPI Wire

ABVC BIOPHARMA, INC.

NASDAQ:ABVC
Annual Meeting

of Shareholders

MEETING DATE

10/28/2026
DEF 14A FILED
09/29/2026
PUBLISHED
09/29/2026 4:22 pm
TIME TO PUBLISH
10/01/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:ABVC · CUSIP 00091F304 · CLASS Common Stock · CIK 0001173313

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To approve the Company’s 2026 Equity Incentive Plan.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the 2026 Plan is intended to replace the 2016 Plan, which terminated on February 16, 2026.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To ratify certain equity awards granted since February 16, 2026.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the Current Awards consist of 600,000 shares of Common Stock granted to two advisors.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve, for purposes of complying with Nasdaq Listing Rules 5635 (a), 5635(b) and 5635(d) (collectively, the “Rules”), the potential issuance of shares of our common stock, $0.001 par value per share (the “Common Stock”) or securities exchangeable for shares of Common Stock, as consideration for the acquisition of certain parcels of land located in Taoyuan and certain real property located in Hualien, Taiwan; specifically, the right to issue up to 1,600,653 shares of Common Stock at a price not less than $1.00 per share (the “Securities Issuance Proposal”).
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states approval would authorize up to 1,600,653 shares for the proposed property acquisition.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

9c30e159567bd59140c7fe747a991c7a11b5787eb1f67d8bb0473baba567da4e

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates